Goldman Sachs Group, Inc. (The) reiterated their buy rating on shares of GlaxoSmithKline plc (LON:GSK) in a research report report published on Thursday, July 20th, Marketbeat Ratings reports. Goldman Sachs Group, Inc. (The) currently has a GBX 1,900 ($25.06) price objective on the stock.
GSK has been the topic of several other research reports. Berenberg Bank raised GlaxoSmithKline plc from a hold rating to a buy rating and upped their price objective for the company from GBX 1,850 ($24.40) to GBX 1,885 ($24.86) in a research report on Friday, May 26th. Jefferies Group LLC upped their price objective on GlaxoSmithKline plc from GBX 1,800 ($23.74) to GBX 1,900 ($25.06) and gave the company a buy rating in a research report on Friday, June 16th. Morgan Stanley set a GBX 1,700 ($22.42) price objective on GlaxoSmithKline plc and gave the company a neutral rating in a research report on Saturday, May 20th. BNP Paribas reaffirmed an underperform rating and issued a GBX 1,520 ($20.05) price objective on shares of GlaxoSmithKline plc in a research report on Wednesday, March 22nd. Finally, HSBC Holdings plc reaffirmed a buy rating and issued a GBX 1,970 ($25.99) price objective on shares of GlaxoSmithKline plc in a research report on Wednesday, May 31st. Four analysts have rated the stock with a sell rating, eleven have given a hold rating and eight have issued a buy rating to the company’s stock. The company has an average rating of Hold and an average target price of GBX 1,734.73 ($22.88).
Shares of GlaxoSmithKline plc (GSK) traded down 0.26% during midday trading on Thursday, reaching GBX 1514.50. 10,180,185 shares of the company were exchanged. The company has a 50 day moving average price of GBX 1,633.67 and a 200-day moving average price of GBX 1,626.93. The stock’s market capitalization is GBX 74.03 billion. GlaxoSmithKline plc has a 12-month low of GBX 1,446.50 and a 12-month high of GBX 1,745.56.
The firm also recently disclosed a dividend, which will be paid on Thursday, October 12th. Shareholders of record on Thursday, August 10th will be issued a GBX 19 ($0.25) dividend. This represents a yield of 1.23%. The ex-dividend date of this dividend is Thursday, August 10th.
In other news, insider Manvinder Singh Banga bought 2,267 shares of the firm’s stock in a transaction dated Wednesday, July 26th. The shares were acquired at an average price of GBX 1,599 ($21.09) per share, for a total transaction of £36,249.33 ($47,816.03). Also, insider Patrick Vallance bought 861 shares of the firm’s stock in a transaction dated Friday, July 14th. The stock was purchased at an average price of GBX 1,618 ($21.34) per share, for a total transaction of £13,930.98 ($18,376.18). Over the last three months, insiders acquired 3,150 shares of company stock worth $5,054,075.
GlaxoSmithKline plc Company Profile
GlaxoSmithKline plc is a global healthcare company. The Company operates through three segments: Pharmaceuticals, Vaccines and Consumer Healthcare. The Company focuses on its research across six areas: Respiratory diseases, human immunodeficiency virus (HIV)/infectious diseases, Vaccines, Immuno-inflammation, Oncology and Rare diseases.
Receive News & Ratings for GlaxoSmithKline plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GlaxoSmithKline plc and related companies with MarketBeat.com's FREE daily email newsletter.
